At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NVOX Defiance Daily Target 2X Long NVO ETF
Pre-Mkt 03-02 06:18:11 EST
10.27
-0.11
-1.06%
盘前10.08
-0.19-1.85%
06:08 EST
High10.50Low10.21Vol1.33M
Open10.35D1 Closing10.38Amplitude2.79%
Mkt Cap37.06MTradable Cap25.66MTotal Shares3.61M
T/O13.78MT/O Rate53.38%Tradable Shares2.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
TIPRANKS  ·  17:25
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs
Novo Nordisk Allocates Over €400 Million to Upgrade Irish Facility for Global Wegovy Production Boost
Stock News  ·  17:11
Novo Nordisk Allocates Over €400 Million to Upgrade Irish Facility for Global Wegovy Production Boost
Novo Nordisk, First Solar, And Corebridge Financial Are Among Top 10 Large Cap Losers Last Week (Feb. 23-Feb. 27): Are the Others in Your Portfolio?
Benzinga  ·  01:31
Novo Nordisk, First Solar, And Corebridge Financial Are Among Top 10 Large Cap Losers Last Week (Feb. 23-Feb. 27): Are the Others in Your Portfolio?
Benzinga Bulls And Bears: Rocket Lab, Kosmos Energy, Novo Nordisk — And Nvidia Fails To Boost Markets
Benzinga_recent_news  ·  02-28 19:42
Benzinga Bulls And Bears: Rocket Lab, Kosmos Energy, Novo Nordisk — And Nvidia Fails To Boost Markets
FDA Approves Novo Nordisk's Growth Disorder Treatment For New Populations
Dow Jones  ·  02-28 05:18
FDA Approves Novo Nordisk's Growth Disorder Treatment For New Populations
FDA approves Novo Nordisk’s Sogroya for three additional pediatric indications
TIPRANKS  ·  02-28 04:55
FDA approves Novo Nordisk’s Sogroya for three additional pediatric indications
Novo Nordisk’s CagriSema Trial Update: What Investors Should Watch in the GLP‑1 Race
TIPRANKS  ·  02-28 00:33
Novo Nordisk’s CagriSema Trial Update: What Investors Should Watch in the GLP‑1 Race
Novo Nordisk (0QIU) Receives a Hold from Barclays
TIPRANKS  ·  02-27 21:36
Novo Nordisk (0QIU) Receives a Hold from Barclays
Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2
Benzinga_recent_news  ·  02-27
Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2
Novo Nordisk A/S Stock Rises Thursday, Outperforms Market
Dow Jones  ·  02-27
Novo Nordisk A/S Stock Rises Thursday, Outperforms Market
Novo Nordisk on Track for Lowest Close Since May 2021 -- Data Talk
Dow Jones  ·  02-27
Novo Nordisk on Track for Lowest Close Since May 2021 -- Data Talk
For the first time in decades, new hair-loss treatments are in the works. Here's how they're different.
Dow Jones  ·  02-26
For the first time in decades, new hair-loss treatments are in the works. Here's how they're different.
Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment
Benzinga_recent_news  ·  02-26
Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT Newswires Live  ·  02-26
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Ozempic Price War - Novo Nordisk Slashes Prices By 50%
Benzinga  ·  02-25
Ozempic Price War - Novo Nordisk Slashes Prices By 50%
Novo Nordisk, Vivtex Collaborate on Oral Biologics for Obesity, Diabetes
MT Newswires Live  ·  02-25
Novo Nordisk, Vivtex Collaborate on Oral Biologics for Obesity, Diabetes
Novo Nordisk Invests Up to $2.1 Billion in Partnership with Vivtex to Advance Next-Generation Oral Weight-Loss Therapies
Stock News  ·  02-25
Novo Nordisk Invests Up to $2.1 Billion in Partnership with Vivtex to Advance Next-Generation Oral Weight-Loss Therapies
NYSE Most Active Issues
Dow Jones  ·  02-25
NYSE Most Active Issues
Exchange Traded Funds Top 10 Percentage Losers
Dow Jones  ·  02-25
Exchange Traded Funds Top 10 Percentage Losers
Novo Nordisk price target lowered to DKK 270 from DKK 340 at Barclays
TIPRANKS  ·  02-25
Novo Nordisk price target lowered to DKK 270 from DKK 340 at Barclays
No data available

Introduction

Company Name.
Defiance Daily Target 2X Long NVO ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
Issue price:
--